Millennium Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,473,868
| Closed | -$133M | – | 6855 |
|
|
2023
Q4 | $133M | Buy |
4,473,868
+2,868,154
| +179% | +$57.1M | 0.06% | 314 |
|
|
2023
Q3 | $25.5M | Sell |
1,605,714
-1,092,149
| -40% | -$18.2M | 0.01% | 1223 |
|
|
2023
Q2 | $50.9M | Sell |
2,697,863
-279,061
| -9% | -$3.29M | 0.03% | 725 |
|
|
2023
Q1 | $11.4M | Buy |
2,976,924
+2,043,204
| +219% | +$8.71M | 0.01% | 1825 |
|
|
2022
Q4 | $4.63M | Sell |
933,720
-907,117
| -49% | -$4.92M | ﹤0.01% | 2879 |
|
|
2022
Q3 | $8.8M | Sell |
1,840,837
-3,216,212
| -64% | -$17M | 0.01% | 2302 |
|
|
2022
Q2 | $22.8M | Buy |
5,057,049
+1,557,032
| +44% | +$6.76M | 0.01% | 1186 |
|
|
2022
Q1 | $16.7M | Sell |
3,500,017
-1,549,274
| -31% | -$8.58M | 0.01% | 1586 |
|
|
2021
Q4 | $37.5M | Buy |
5,049,291
+2,101,770
| +71% | +$13.1M | 0.02% | 917 |
|
|
2021
Q3 | $16.7M | Buy |
2,947,521
+324,613
| +12% | +$1.88M | 0.01% | 1491 |
|
|
2021
Q2 | $17.3M | Buy |
2,622,908
+380,607
| +17% | +$2.66M | 0.01% | 1327 |
|
|
2021
Q1 | $18.2M | Buy |
2,242,301
+288,827
| +15% | +$2.36M | 0.01% | 1175 |
|
|
2020
Q4 | $12.6M | Sell |
1,953,474
-2,801,900
| -59% | -$16.3M | 0.01% | 1490 |
|
|
2020
Q3 | $17.1K | Buy |
4,755,374
+769,380
| +19% | +$3.11M | 0.02% | 885 |
|
|
2020
Q2 | $18.3M | Buy |
3,985,994
+2,007,736
| +101% | +$8.54M | 0.03% | 787 |
|
|
2020
Q1 | $6.75M | Sell |
1,978,258
-991,321
| -33% | -$4.33M | 0.02% | 1116 |
|
|
2019
Q4 | $15.2M | Buy |
2,969,579
+1,046,725
| +54% | +$3.55M | 0.02% | 1030 |
|
|
2019
Q3 | $4.65M | Sell |
1,922,854
-295,201
| -13% | -$784K | 0.01% | 1866 |
|
|
2019
Q2 | $4.81M | Buy |
2,218,055
+936,879
| +73% | +$2.22M | 0.01% | 1814 |
|
|
2019
Q1 | $3.47M | Sell |
1,281,176
-3,108,084
| -71% | -$13.5M | 0.01% | 2012 |
|
|
2018
Q4 | $21.1M | Buy |
4,389,260
+3,552,118
| +424% | +$21.6M | 0.03% | 695 |
|
|
2018
Q3 | $7.93M | Buy |
837,142
+579,938
| +225% | +$5.57M | 0.01% | 1475 |
|
|
2018
Q2 | $2.5M | Sell |
257,204
-1,373,778
| -84% | -$14.5M | ﹤0.01% | 2248 |
|
|
2018
Q1 | $17.2M | Sell |
1,630,982
-1,310,505
| -45% | -$12.9M | 0.02% | 969 |
|
|
2017
Q4 | $18.9M | Sell |
2,941,487
-845,940
| -22% | -$5.22M | 0.03% | 936 |
|
|
2017
Q3 | $29M | Sell |
3,787,427
-242,030
| -6% | -$1.61M | 0.04% | 588 |
|
|
2017
Q2 | $28.6M | Buy |
4,029,457
+2,922,762
| +264% | +$13.4M | 0.05% | 524 |
|
|
2017
Q1 | $4.28M | Sell |
1,106,695
-1,111,655
| -50% | -$3.24M | 0.01% | 1555 |
|
|
2016
Q4 | $4.53M | Buy |
2,218,350
+404,030
| +22% | +$811K | 0.01% | 1390 |
|
|
2016
Q3 | $4.86M | Buy |
1,814,320
+189,812
| +12% | +$552K | 0.01% | 1354 |
|
|
2016
Q2 | $5M | Buy |
+1,624,508
| New | +$10.2M | 0.01% | 1259 |
|
|
2016
Q1 | – | Sell |
-30,926
| Closed | -$420K | – | 3757 |
|
|
2015
Q4 | $420K | Sell |
30,926
-1,524,304
| -98% | -$18.8M | ﹤0.01% | 2737 |
|
|
2015
Q3 | $14.9M | Sell |
1,555,230
-2,413,542
| -61% | -$35.3M | 0.03% | 706 |
|
|
2015
Q2 | $57.1M | Buy |
3,968,772
+3,029,108
| +322% | +$33.3M | 0.11% | 226 |
|
|
2015
Q1 | $8.41M | Sell |
939,664
-549,771
| -37% | -$3.98M | 0.02% | 1121 |
|
|
2014
Q4 | $9.09M | Buy |
1,489,435
+1,342,935
| +917% | +$12.3M | 0.02% | 1054 |
|
|
2014
Q3 | $1.55M | Sell |
146,500
-1,494
| -1% | -$16.9K | ﹤0.01% | 2033 |
|
|
2014
Q2 | $1.75M | Buy |
147,994
+47,994
| +48% | +$602K | ﹤0.01% | 1867 |
|
|
2014
Q1 | $1.49M | Hold |
100,000
| – | – | ﹤0.01% | 1982 |
|
|
2013
Q4 | $1.47M | Buy |
100,000
+31,365
| +46% | +$482K | ﹤0.01% | 2044 |
|
|
2013
Q3 | $1.17M | Buy |
+68,635
| New | +$1.21M | ﹤0.01% | 2007 |
|
Other funds holding IMGN
Millennium Management's IMGN Position: Q1 2024 in Review
Millennium Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 4,473,868 shares — an estimated $133M sold.
Millennium Management first reported a position in IMGN in Q3 2013 and held it in 41 quarters. The position peaked at $133M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Millennium Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 4,473,868 Immunogen Inc shares in Q1 2024, an estimated $133M.
- Millennium Management first reported a position in Immunogen Inc in Q3 2013 and held it in 41 quarters.
- Millennium Management's Immunogen Inc position peaked at $133M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.